How to treat diffuse intravascular coagulation

The common causes of disseminated intravascular coagulation mainly include meningococcus, epidemic hemorrhagic fever, lymphoma, etc. Targeted treatments, such as medication and surgery, need to be carried out under the guidance of doctors.
1. Doctors will treat patients according to their clinical manifestations and the staging of disseminated intravascular coagulation. For example, in the early stage of disseminated intravascular coagulation, commonly used medications include ordinary heparin and low molecular heparin; in the middle stage, appropriate transfusion of coagulation factors and blood products is considered; and in the late stage, appropriate antifibrinolytic drugs (e.g., aminocryptine) can be chosen to treat secondary fibrinolysis, but active treatment of the primary disease is also required.
2. For example, meningococcus needs timely antimicrobial treatment, commonly used drugs include penicillin, chloramphenicol, third-generation cephalosporins, etc.; epidemic hemorrhagic fever early application of antiviral therapy (e.g., ribavirin); lymphoma commonly used immunomodulators such as cedarbenazine and other immunomodulators, as well as azathioprine + vincristine + proparbazide + prednisone combination of chemotherapy regimens, and if necessary, consider radiotherapy, surgery, etc..
However, other factors cannot be ruled out, and the treatment of the primary disease is the key to terminate the pathological process of disseminated intravascular coagulation; it is recommended that the patient further clarify the cause of the disease, and standardize the treatment in accordance with the doctor’s instructions.